Acute Toxic and Teratogenic Effects of Cyclic Imides in Rodents

Four structurally different cyclic imides or related derivatives (o‐(N‐phthalimido)acetophenone (1), 2,3‐dihydrophthalazine‐1,4‐dione (2), N‐(4‐methylphenyl)diphenamide (3), and 4,6‐dihydro‐5H‐dibenz[c,e]azepine (4) were examined for acute toxicity in mice at multiple doses, for long term toxicity at a single dose in rats, and for deleterious effects on fertility and pup development in rodents. No deleterious effects were observed when mice were administered agents at 20, 50, and 100 mg/kg/day for seven days. All other measured characteristics and values were normal for the four compounds. The principle effect of the compounds was to reduce the percent pregnancies in treated mice compared to the controls. Compound 2 afforded the greatest reduction of pregnancy (54%) at 100 mg/kg/day. Compounds 3 and 4 caused a minor reduction in pregnancy (12‐20%). The compounds did not appear to cause measureable teratogenic effects; pups of treated rodents thrived and survived as well as controls. There were no effects on murine male fertility when compounds were administered at 20, 50, and 100 mg/kg/day for six weeks.

[1]  I. Hall,et al.  The anti‐neoplastic activity of 2,3‐dihydrophthalazine‐1,4‐dione and N‐butyl‐2,3‐dihydrophthalazine‐1,4‐dione in human and murine tumor cells , 1992, Anti-cancer drugs.

[2]  S. Chaney,et al.  Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 mice. , 1990, Toxicology.

[3]  I. Hall,et al.  The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents. , 1987, Pharmacological research communications.

[4]  S. Wyrick,et al.  Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents. , 1986, Journal of pharmaceutical sciences.

[5]  S. Wyrick,et al.  Hypolipidemic activity of N-substituted diphenimides in rodents , 1985 .

[6]  I. Hall,et al.  Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives. , 1983, Journal of medicinal chemistry.

[7]  T. Shepard,et al.  Methods for detection of environmental agents that produce congenital defects : proceedings of the Guadeloupe Conference , 1975 .

[8]  L. Saxén,et al.  Human teratogenesis: invitro studies on thalidomide-inhibited chondrogenesis. , 1972, Developmental biology.

[9]  N. Tietz Fundamentals of Clinical Chemistry , 1970 .

[10]  I. Hall,et al.  Effects of two metabolites of norethynodrel on reproductive performance of female rats. , 1970, Fertility and sterility.

[11]  J. Coppola An extragonadal male antifertility agent. , 1969, Life sciences.

[12]  W. Lenz Malformations caused by drugs in pregnancy. , 1966, American journal of diseases of children.

[13]  A. C. Peacock,et al.  EVALUATION OF A RECENTLY REPORTED STABLE LIEBERMANN-BURCHARD REAGENT AND ITS USE FOR THE DIRECT DETERMINATION OF SERUM TOTAL CHOLESTEROL. , 1964, Clinica chimica acta; international journal of clinical chemistry.

[14]  W. Mcbride,et al.  Thalidomide and Congenital Abnormalities , 1961 .

[15]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.